With cruise ship voyages reporting additional norovirus outbreaks in 2025, vaccines that protect people against human norovirus disease are in demand.
Historically, developing a broadly effective norovirus vaccine has been challenging owing to the genetic and antigenic diversity of noroviruses.
Another concern has arisen due to Moderna Inc.'s recent announcement.
Read More
